Literature DB >> 12633527

A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.

J Chilcott1, M Lloyd Jones, J Wight, K Forman, J Wray, C Beverley, P Tappenden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12633527     DOI： 10.3310/hta7040

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  13 in total

1.  Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.

Authors:  Francesco Bennardello; Giuseppe Curciarello
Journal:  Blood Transfus       Date:  2013-06-14       Impact factor: 3.443

Review 2.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

3.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

4.  The importance of antenatal prevention of RhD immunisation in the first pregnancy.

Authors:  Slavica Dajak; Damir Roje; Željka Hundrić Hašpl; Pera Erceg Maglić
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

Review 5.  Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2020-11-02

6.  Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.

Authors:  Sylwia Bujkiewicz; Hayley E Jones; Monica C W Lai; Nicola J Cooper; Neil Hawkins; Hazel Squires; Keith R Abrams; David J Spiegelhalter; Alex J Sutton
Journal:  Value Health       Date:  2011-04-30       Impact factor: 5.725

7.  A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.

Authors:  Ala Szczepura; Leeza Osipenko; Karoline Freeman
Journal:  BMC Pregnancy Childbirth       Date:  2011-01-18       Impact factor: 3.007

8.  Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Authors:  Rebecca M Turner; Myfanwy Lloyd-Jones; Dilly O C Anumba; Gordon C S Smith; David J Spiegelhalter; Hazel Squires; John W Stevens; Michael J Sweeting; Stanislaw J Urbaniak; Robert Webster; Simon G Thompson
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

9.  Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Authors:  J M Koelewijn; M de Haas; T G M Vrijkotte; C E van der Schoot; G J Bonsel
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

10.  Bias modelling in evidence synthesis.

Authors:  Rebecca M Turner; David J Spiegelhalter; Gordon C S Smith; Simon G Thompson
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2009-01       Impact factor: 2.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.